Showing BioInteractions for Human immunoglobulin G (DB00028)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Low affinity immunoglobulin gamma Fc region receptor III-B antagonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-B binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-B ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-B agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Low affinity immunoglobulin gamma Fc region receptor III-A antagonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-A binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-A ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-A bindings | Benralizumab |
| 4 | Low affinity immunoglobulin gamma Fc region receptor III-A agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a High affinity immunoglobulin gamma Fc receptor I antagonist | ||
| 1 | High affinity immunoglobulin gamma Fc receptor I antagonists | Porfimer sodium |
| 2 | High affinity immunoglobulin gamma Fc receptor I binders | Atomoxetine, Cetuximab |
| 3 | High affinity immunoglobulin gamma Fc receptor I ligands | Etanercept |
| 4 | High affinity immunoglobulin gamma Fc receptor I agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Low affinity immunoglobulin gamma Fc region receptor II-a antagonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor II-a binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor II-a ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor II-a agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Low affinity immunoglobulin gamma Fc region receptor II-b antagonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor II-b ligands | Etanercept |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Low affinity immunoglobulin gamma Fc region receptor II-c antagonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor II-c ligands | Etanercept |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a High affinity immunoglobulin gamma Fc receptor IB antagonist | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Complement C3 binder | ||
| 1 | Complement C3 inhibitors | Zinc chloride, Zinc sulfate, unspecified form |
| 2 | Complement C3 ligands | Zinc chloride, Zinc sulfate, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Complement C4-A binder | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Complement C4-B binder | ||
| 1 | Complement C4-B modulators | Zinc chloride, Zinc sulfate, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Human immunoglobulin G is a Complement C5 binder | ||
| 1 | Complement C5 ligands | Zinc chloride, Zinc sulfate, unspecified form |
| 2 | Complement C5 inhibitors | Ravulizumab |